General form of registration statement for all companies including face-amount certificate companies

Note 20 - Revision of Prior Period Financial Statements

v3.24.3
Note 20 - Revision of Prior Period Financial Statements
12 Months Ended
Dec. 31, 2023
Notes to Financial Statements  
Error Correction [Text Block]

NOTE 20: REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS

 

During 2023, management of the Company became aware of certain errors in the recording of expenses within research and development and general and administrative expenses in the consolidated statement of operations and comprehensive loss for the year ended December 31, 2022. Revisions of these amounts are reflected in the following tables.

 

Revised Consolidated Balance Sheet

 

   

As of December 31, 2022

 
   

As reported

   

Adjustment

   

As revised

 

Accrued liabilities

    740       115       855  

Total current liabilities

    2,246       115       2,361  

Total liabilities

    2,246       115       2,361  

Accumulated deficit

    (73,906 )     (115 )     (74,021 )

Total shareholders’ deficit

    (2,111 )     (115 )     (2,226 )

 

Revised Consolidated Statements of Operations and Comprehensive Loss

 

   

For the year ended December 31, 2022

 
   

As reported

   

Adjustment

   

As revised

 

Research and development expenses

    1,272       27       1,299  

General and administration expenses

    1,454       88       1,542  

Total operating expenses

    3,329       115       3,444  

Loss before Income Tax

    (3,789 )     (115 )     (3,904 )

Net Loss and Comprehensive Loss

    (3,789 )     (115 )     (3,904 )

 

Revised Consolidated Statement of Cash Flows

 

   

For the year ended December 31, 2022

 
   

As reported

   

Adjustment

   

As revised

 

Net loss

    (3,789 )     (115 )     (3,904 )

Change in accrued liabilities

    (18 )     115       97  

Net cash used in operating activities

    (2,892 )     -       (2,892 )